Impact of Mineralocorticoid Receptor Antagonism in a New Model of Diabetic Kidney Disease

被引：0
|
作者：
Ramirez, Roberto Palacios [1 ]
Posada, Ixchel Q. Lima [1 ]
Bonnard, Benjamin [1 ]
Genty, Marie [1 ]
Hartleib-Geschwindner, Judith [2 ]
Foufelle, Fabienne [1 ]
Bamberg, Krister [2 ]
Jaisser, Frederic [1 ]
机构：
[1] INSERM, Paris, France
[2] AstraZeneca, Gothenburg, Sweden
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0659
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] Finerenone: A New Era for Mineralocorticoid Receptor Antagonism and Cardiorenal Protection
    Parfianowicz, Dominic
    Shah, Swara
    Nguyen, Catherine
    Maitz, Theresa N.
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Aronow, Wilbert S.
    Vyas, Apurva
    Gupta, Rahul
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (12)
  • [42] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Bomback, Andrew S.
    Klemmer, Philip J.
    BLOOD PURIFICATION, 2012, 33 (1-3) : 119 - 124
  • [43] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Volk, Matthew J.
    Bomback, Andrew S.
    Klemmer, Philip J.
    CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 282 - 288
  • [44] Clinical effect of nonsteroidal mineralocorticoid receptor (MR) antagonists in the treatment of diabetic kidney disease: expectations as a new therapeutic strategy
    Atsuhisa Sato
    Mitsuhiro Nishimoto
    Hypertension Research, 2022, 45 : 1310 - 1321
  • [45] Clinical effect of nonsteroidal mineralocorticoid receptor (MR) antagonists in the treatment of diabetic kidney disease: expectations as a new therapeutic strategy
    Sato, Atsuhisa
    Nishimoto, Mitsuhiro
    HYPERTENSION RESEARCH, 2022, 45 (08) : 1310 - 1321
  • [46] Mineralocorticoid receptor antagonism in experimental atherosclerosis
    Rajagopalan, S
    Duquaine, D
    King, S
    Pitt, B
    Patel, P
    CIRCULATION, 2002, 105 (18) : 2212 - 2216
  • [47] Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists
    Mende, Christian Werner
    Samarakoon, Rohan
    Higgins, Paul J.
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (1-2) : 50 - 61
  • [48] Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
    Bauersachs, Johann
    Lother, Achim
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2022, 12 (01) : 19 - 26
  • [49] The Promise of Mineralocorticoid Antagonism in Acute Kidney Injury
    Chandrashekar, Kiran B.
    Lopez-Ruiz, Arnaldo
    Juncos, Luis A.
    NEPHRON, 2016, 134 (03) : 154 - 159
  • [50] A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
    Fagart, Jerome
    Hillisch, Alexander
    Huyet, Jessica
    Baerfacker, Lars
    Fay, Michel
    Pleiss, Ulrich
    Pook, Elisabeth
    Schaefer, Stefan
    Rafestin-Oblin, Marie-Edith
    Kolkhof, Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (39) : 29932 - 29940
12345